Advertisement: TTP Killer 50
14 October, 2013 - 12:10 By News Desk

Owlstone Medical

Billy Boyle Owlstone Tony Blair

Owlstone Medical has raised big money in recent months to commercialise its disease breathalyser. 

The business was spun out of parent, Owlstone Inc, by co-founder Billy Boyle to develop and commercialise the breath test for use in clinical diagnostics and precision medicine with applications in cancer, inflammatory and infectious disease.

Former PM Tony Blair paid tribute to the company on a visit to its Cambridge HQ. In April 2017, the company signed a collaboration agreement with the world-renowned Mayo Clinic which will evaluate its FAIMS technology as a rapid, point-of-care test to non-invasively assess the adequacy of bowel preparation prior to colonoscopy.

owlstonemedical.com

 

Newsletter Subscription

Stay informed of the latest news and features